No 10Y consistency score yet for revenue — the window needs more comparable quarters.
Valuation vs own 10Y history: P/S 36.9x · 10Y median 294.4x · 6th percentile · as of Oct 5, 2026
Annualized revenue (TTM) · by quarter, last 18
Quarterly YoY revenue growth vs the 20% line
P/S multiple vs its 10Y median
FMP quote market capitalization / revenue from four consecutive issuer fiscal quarters. Quote observation: 2026-10-06T12:01:16.935Z. Latest historical point 2026-10-05. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
The latest delayed quote for Bullfrog AI Holdings, Inc. Common Stock (BFRG) stock was $0.59 as of Oct 5, 2026, 4:00 PM EDT, down 3.81% from the previous close.
Longer view (total return, dividends reinvested): past 12 months -58.6% · 3-year avg -42.2%/yr
BullFrog AI Holdings, Inc., along with its affiliated entities, functions as an advanced digital biopharmaceutical firm. Its core mission involves harnessing artificial intelligence and machine learning (AI/ML) to process and interpret extensive medical and healthcare datasets specifically within the United States.
Medical - Healthcare Information Services · Gaithersburg, MD
Next Earnings Date
Nov 13, 2026
38 days away
EPS Estimate
-0.09
Revenue Est.
$215000.00
Last Quarter Results
EPS
$-0.07
vs Estimate
$-0.11
Revenue
| Stock | Market Cap | Close Price | Price Change | TTM Total Return | 5Y CAGR | 10Y CAGR | Compare |
|---|---|---|---|---|---|---|---|
| 1BFRG | $11.01M | $0.59 | -3.81% | -58.58% | N/A | N/A | N/A |
| 2BIVI | $10.86M | $1.44 | -1.37% | -26.05% | -70.37% | -54.09% | vs BFRG |
| 3CNSY | $10.74M | $1.56 | -2.50% | N/A | N/A | N/A | vs BFRG |
| 4BFRI | $11.41M | $0.89 | -12.23% | -16.67% | N/A | N/A | vs BFRG |
| 5ADIL | $11.42M | $4.35 | +5.58% | -56.33% | -71.86% | N/A | vs BFRG |
| 6CABR | $10.27M | $1.13 | -2.59% | -69.29% | N/A | N/A | vs BFRG |
forward FY estimate
N/A
$215000.00
vs Estimate
$215000.00
Consensus Rating
No analyst recommendations available
Average Price Target
N/A
Low
N/A
Current
$0.59
High
N/A
Quarterly
| Period | Low | Avg | High | # Analysts |
|---|---|---|---|---|
| Quarter ending Sep 2026 | $-0.09 | $-0.09 | $-0.09 | 1 |
| Quarter ending Dec 2026 | $-0.10 | $-0.10 | $-0.10 | 1 |
| Quarter ending Mar 2027 | $-0.05 | $-0.05 | $-0.05 | 1 |
| Quarter ending Jun 2027 | $-0.05 | $-0.05 | $-0.05 | 1 |
Annual
| Period | Low | Avg | High | # Analysts |
|---|---|---|---|---|
| FY 2026 | $-0.37 | $-0.37 | $-0.37 | 1 |
| FY 2027 | $-0.17 | $-0.17 | $-0.17 | 1 |
Quarterly
| Period | Low | Avg | High | # Analysts |
|---|---|---|---|---|
| Quarter ending Sep 2026 | $215000.00 | $215000.00 | $215000.00 | 1 |
| Quarter ending Dec 2026 | $350000.00 | $350000.00 | $350000.00 | 1 |
| Quarter ending Mar 2027 | $750000.00 | $750000.00 | $750000.00 | 1 |
| Quarter ending Jun 2027 | $750000.00 | $750000.00 | $750000.00 | 1 |
Annual
| Period |
|---|
Source: FMP Analyst Consensus Estimates. Forward P/E is unavailable for the current price and estimate observations.
| Low |
|---|
| Avg |
|---|
| High |
|---|
| # Analysts |
|---|
| FY 2026 | $780000.00 | $780000.00 | $780000.00 | 1 |
| FY 2027 | $5.25M | $5.25M | $5.25M | 1 |
